The FDA's recently released draft guidance on diversity action plans for clinical trials has brought renewed focus on increasing the representation of underrepresented populations in clinical trials. The plan aims to address long-standing disparities in health outcomes and ensure that new treatments are tested adequately within diverse communities. BDO hosted a virtual town hall discussing […]